Skip to content
Search
By  Justin P. White

Disciplined investing amid a dynamic U.S. market environment

Looking toward 2025, U.S. equity market returns are likely to be harder earned.

November 2024, From the Field -

Key Insights
  • The U.S. equity market has rallied back strongly from a period of heightened volatility in August. While some of the root cause headwinds have eased, they have not disappeared.
  • The outlook for U.S. equities appears finely balanced. Looking toward 2025, we anticipate a higher level of volatility, with markets more sensitive to macro/corporate news flow.
  • While U.S. equity returns are likely to be harder earned, for disciplined investors who stay anchored to fundamentals and reject false narratives, this environment provides opportunity.

After a turbulent August, U.S. equity markets have rallied back in recent months, soothed (initially) by U.S. jobless claims data, falling inflation, and a larger‑than‑anticipated cut in interest rates. But, while sentiment has certainly improved since August’s downturn, an undertone of nagging uncertainty remains. And, as we look toward the new year, the U.S. equity market outlook appears finely balanced. On the one hand, tailwinds including a growing economy, robust corporate earnings, moderating inflation, and easier monetary policy are all reasons for encouragement. However, these are balanced out by various headwinds, including a volatile jobs market, negative earnings revisions in the equal‑weighted S&P 500 Index, prospective policy uncertainty, as well as heightened geopolitical tensions. 

Given these competing forces, sensitivity to news flow—and the prospect of a higher level of market volatility—is expected to be a feature moving forward. While this can be unsettling, it is also a broadly supportive backdrop for active, process‑driven stock picking, as company valuations and fundamental quality come sharply into focus, and the potential for investor overreaction also increases.

Expectations remain for an economic soft landing

The larger‑than‑expected 50‑basis‑point rate cut by the U.S. Federal Reserve in September—the first in four years—followed by another 25‑basis point reduction in November, are decisive policy moves, designed to shore up consumer confidence and underpin a flagging labor market. Interest rate cuts are a boost for sentiment in the near term, even though more tangible impacts will take time to flow through to the economy.

We do not envisage any looming credit stress at either a consumer or a corporate level. Consumer balance sheets are certainly less flush than a couple of years ago, but they are still relatively healthy compared with history. At a corporate level, some concerns have been raised about the massive investment that companies are making in artificial intelligence (AI), for example. However, this looks like it is being funded largely from free cash flow rather than from a ramping up of debt.

Looking toward 2025, our baseline expectation is for an economic soft landing in the U.S., but our conviction is closely tied to the U.S. labor market. Recent jobs data updates underscore the difficulty in formulating a clear view of what is a volatile and “noisy” dataset (Fig. 1). Having been revised lower in the previous months, jobs data surprised strongly to the upside in September, with employers adding an expectation‑busting 223,000 new jobs. However, the latest figures for October show an almost polar opposite result, with just 12,000 new jobs added, the lowest level in nearly four years and well short of the expected 117,500 jobs. It is too early to say which of these signals is more reflective of the actual landscape, or how near, or otherwise, we are from seeing a stabilization in the U.S. jobs market.

Examining the “broadening market” narrative

From a market perspective, we anticipate a slow grind higher on the U.S. equity market in the near term, interspersed with periods of heightened volatility as markets react to macro data and corporate earnings surprises.

"While some of the root cause headwinds behind the August market correction have been diluted, they have not disappeared altogether."

U.S. employment data continues to be volatile

(Fig. 1) Total non‑farm payroll data—monthly new jobs created

As of November 5, 2024.
1 Median estimate.
Source: The Bureau of Labor Statistics (BLS) and T. Rowe Price calculations using data from FactSet Research Systems Inc. All rights reserved.2

While some of the root cause headwinds behind the August market correction have been diluted, they have not disappeared altogether. High market concentration, for example, remains an ongoing issue to negotiate.

Encouragingly, the “broadening market” narrative is gradually being borne out in reality, at least across industries/sectors. This is certainly beneficial for larger, growth‑oriented holdings outside the “Magnificent Seven” stocks. However, the broadening of market performance is much less apparent down the market capitalization spectrum. Company scale is benefiting the larger players in most industries, and this is creating an earnings divide between large and smaller U.S. companies. Furthermore, substantial investment in artificial intelligence (AI) is being dominated by large companies with deep pockets. Smaller companies simply cannot compete, putting them at a relative disadvantage, given the enhanced productivity and decision‑making potential that AI offers.

With so much investor attention focused at the top end of the market, smaller companies have effectively been relegated to the background in recent years. As a result, rather than being driven by individual company or industry‑specific fundamentals, the small‑cap market is currently moving in broad unison, swayed by headline macro data, as well as basket purchase programs such as exchange‑traded funds. On the release of each important data point, it seems the market decides if the associated narrative is uniformly good for small‑caps or uniformly bad. Given the less liquid nature of the small‑cap market, this can result in heightened price volatility, and we are seeing more instances of these kinds of directional moves. Looking ahead, we see underappreciated value in U.S. smaller companies, but we would need to see some sort of catalyst or fundamental shift in the landscape in order for this value to be broadly realized.

Earnings remain supportive

The second‑quarter 2024 U.S. corporate earnings season proved positive, with a higher‑than‑average number of S&P 500 companies (79%) reporting positive earnings surprises.1 Expectations are for this positive earnings momentum to continue in the near term, albeit with a potentially lower number of aggregate companies announcing upside earnings surprises. It is also worth noting that the magnitude of earnings surprises weakened in the second quarter, suggesting that gains will likely be harder won moving forward. Within the technology sector, for example, the size of earnings per share beats (versus expectations) was the lowest in multiple quarters.

Nevertheless, consensus earnings expectations remain bullish for the third and fourth quarters of 2024, and even more so in 2025, as lower inflation and interest rate cuts begin to flow through to provide further support for company earnings.

Amid volatility, markets behaved rationally

One of the more surprising, and encouraging, features of the recent August volatility was that U.S. equity markets generally behaved rationally. Most sectors and stocks performed in line with their respective earnings per share revisions, while any stocks that exceeded or missed expectations were rewarded and punished, respectively. This is precisely how efficient markets should function, leading to a broader dispersion in returns as better‑quality companies with improving fundamentals separate from lower‑quality ones. In this environment, the importance of a consistent, process‑driven stock‑picking framework increases greatly.

Heath care offers attractive attributes

The health care sector, for example, is currently presenting attractive investment opportunities, in our view. The sector encompasses a range of industries and a wide array of businesses, many of which we believe appear reasonably valued. In addition to the health care sector’s inherent defensive characteristics, many companies appear to feature compelling idiosyncratic and durable growth stories.

Looking longer term, it is going to be fascinating to see how AI impacts the health care sector, from advancement in robotics and precision surgery to enabling the discovery and diagnosis of novel treatments. The technology is still in its infancy, but AI could have a disruptive impact in terms of greatly improved patient treatment/long‑term care. Identifying the likely winners at an early stage represents a potentially huge investment opportunity.  

Conclusion

The recent third‑quarter market downturn and subsequent strong rebound are a reminder as to just how quickly market confidence can change. Sentiment has certainly been boosted by the larger‑than‑expected cut in U.S. interest rates, along with company earnings that have also remained strong. At the same time, however, industrial activity is softening, the U.S. election and geopolitical events add uncertainty, and there are signs that consumers—at least at the lower end of the earnings scale—are moderating their spending.

Given the finely balanced outlook, U.S. equities could see a higher level of volatility in 2025 as sentiment shifts in reaction to the latest macroeconomic data and earnings updates. While returns will be harder earned in this environment, volatility presents opportunities for active managers who stay anchored to fundamentals and reject false narratives to find mispriced companies. In our view a  robust process for identifying good‑quality businesses that are reasonably priced will be the key to outperforming.

Justin P. White Portfolio Manager, All‑Cap Opportunities Fund

Justin White is a portfolio manager of the US Multi-Cap Growth Equity Strategy, including the T. Rowe Price All-Cap Opportunities Fund, in the U.S. Equity Division. He is chairman of the Investment Advisory Committee of the US Multi-Cap Growth Equity Strategy and a vice president and an Investment Advisory Committee member of the US Structured Research Equity, US Growth Stock, US Large-Cap Core Growth Equity, US Mid-Cap Value Equity, and Communications and Technology Equity Strategies. He is a member of the Asset Allocation and Equity Steering Committees. Justin is a vice president of T. Rowe Price Group, Inc.


 

Download PDF

1 FactSet, as of October 18, 2024.

Important Information

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.

Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only.

Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45-106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.

EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.

New Zealand—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.

Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.

UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.

USA—Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.

© 2024 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.

202411-4019923

Download

Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel

Download

Share Class: Language of the document:
Download Cancel
Sign in to manage subscriptions for products, insights and email updates.
Continue with sign in?
To complete sign in and be redirected to your registered country, please select continue. Select cancel to remain on the current site.
Continue Cancel
Once registered, you'll be able to start subscribing.

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the 27-year period ended June 30, 2023, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest